Quilter PLC Intellia Therapeutics, Inc. Transaction History

Quilter PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$100.76 - $138.36 $236,786 - $325,146	-2,350 Closed	0 $0
Q3 2021 Nov 04, 2021	SELL	$132.37 - $176.78 $68,302 - $91,218	-516 Reduced 18.0%	2,350 $315,000
Q2 2021 Aug 12, 2021	BUY	$60.88 - $161.91 $3,104 - $8,257	51 Added 1.81%	2,866 $464,000
Q1 2021 May 12, 2021	SELL	$46.59 - $83.68 $41,698 - $74,893	-895 Reduced 24.12%	2,815 $226,000
Q4 2020 Feb 12, 2021	BUY	$18.83 - $63.53 $69,859 - $235,696	3,710 New	3,710 $202,000

313

89.3M

686K

599K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $1.7B
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Quilter PLC, based on Form 13F filings with the SEC.

Stay updated on Quilter PLC with notifications on news.